15 studies found for:    lesinurad
Show Display Options
Rank Status Study
1 Completed Bioavailability of Lesinurad and Intravenous [14C]Lesinurad
Condition: Healthy
Interventions: Drug: Lesinurad 400 mg;   Drug: [14C]lesinurad (100 μg per 10 mL)
2 Active, not recruiting Lesinurad Tablet Relative Bioavailability
Condition: Healthy
Interventions: Drug: Lesinurad 400 mg (Site 1);   Drug: Lesinurad 400 mg (Site 2, Lot A);   Drug: Lesinurad 400 mg (Site 2, Lot B)
3 Completed Lesinurad Interaction Study With Ranitidine
Condition: Healthy
Interventions: Drug: lesinurad 400 mg;   Drug: ranitidine 150 mg;   Drug: lesinurad 400 mg + ranitidine 150 mg
4 Active, not recruiting Lesinurad Tablet Bioequivalence
Condition: Healthy
Interventions: Drug: Lesinurad 400 mg (manufactured at Site 1);   Drug: Lesinurad 400 mg (manufactured at Site 2)
5 Enrolling by invitation Lesinurad and Allopurinol Combination Extension Study in Gout
Condition: Gout
Intervention: Drug: Lesinurad
6 Enrolling by invitation Lesinurad and Febuxostat Combination Extension Study in Gout
Condition: Gout
Intervention: Drug: lesinurad
7 Completed NSAID Drug Interaction Study
Condition: Gout
Interventions: Drug: lesinurad 400 mg;   Drug: naproxen 250 mg;   Drug: indomethacin 25 mg
8 Completed Single and Multiple Dose Study in Japanese
Condition: Gout
Interventions: Drug: Lesinurad;   Drug: Placebo
9 Completed Antacid Interaction Study
Condition: Healthy
Interventions: Drug: Lesinurad 400 mg;   Drug: Tums 500 mg and 750 mg;   Drug: MINTOX 10 mL
10 Completed Combining Lesinurad With Allopurinol in Inadequate Responders
Condition: Gout
Interventions: Drug: Lesinurad;   Drug: Placebo
11 Completed Combining Lesinurad With Allopurinol in Inadequate Responders
Condition: Gout
Interventions: Drug: Lesinurad;   Drug: Placebo
12 Completed Combination Treatment Study in Subjects With Tophaceous Gout With Lesinurad and Febuxostat
Condition: Tophaceous Gout
Interventions: Drug: Lesinurad;   Drug: Placebo
13 Completed Metformin and Furosemide Drug-Drug Interaction Study
Condition: Healthy
Interventions: Drug: Lesinurad 400 mg;   Drug: Metformin 850 mg;   Drug: Furosemide 40 mg
14 Completed Lesinurad Monotherapy in Gout Subjects Intolerant to Xanthine Oxidase Inhibitors
Condition: Gout
Interventions: Drug: lesinurad;   Drug: Placebo
15 Completed Open-Label Lesinurad Monotherapy Extension Study in Gout
Condition: Gout
Intervention: Drug: lesinurad

Indicates status has not been verified in more than two years